Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis

Stefano Molica; Tycho Baumann; Diana Giannarelli

doi:10.1111/ejh.13548

Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis

Stefano Molica, Tycho Baumann, Diana Giannarelli

Istituto Regina Elena

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	European Journal of Haematology
DOIs	https://doi.org/10.1111/ejh.13548
Publication status	Accepted/In press - 2020

Keywords

CLL
ibrutinib
performance analysis
prognostic models

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/ejh.13548

Cite this

@article{81fd865868de43ec957ccf4d94a77b28,

title = "Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis",

keywords = "CLL, ibrutinib, performance analysis, prognostic models",

author = "Stefano Molica and Tycho Baumann and Diana Giannarelli",

year = "2020",

doi = "10.1111/ejh.13548",

language = "English",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy

T2 - Results of a comparative performance analysis

AU - Molica, Stefano

AU - Baumann, Tycho

AU - Giannarelli, Diana

PY - 2020

Y1 - 2020

KW - CLL

KW - ibrutinib

KW - performance analysis

KW - prognostic models

UR - http://www.scopus.com/inward/record.url?scp=85096841844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096841844&partnerID=8YFLogxK

U2 - 10.1111/ejh.13548

DO - 10.1111/ejh.13548

M3 - Letter

C2 - 33190324

AN - SCOPUS:85096841844

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

ER -

Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this